Press Releases

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. ("E.F. Hutton"), a leading investment banking and financial advisory firm, today announced that it served as financial advisor to VCI Global Limited (NASDAQ:VCIG) ("VCI Global"), an AI-native operating platform designed to scale and optimize businesses through centralized intelligence, data, and capital discipline, in connection with the exercise of outstanding warrants, generating gross proceeds of approximately $6.87 million. As part of the transaction, existing warrant holder Esousa Group Holdings, LLC, a New York-based family office, elected to exercise warrants into 880,000 shares of VCI Global common stock at an exercise

Initiative aims to fast-track digital infrastructure, unlock scalable AI adoption, and underpin sustainable long-term economic growth in Ukraine. Dubai, Kyiv, and New York, June 26, 2026 – VEON Ltd. (NASDAQ:VEON), a global digital operator and the parent company of Kyivstar Group Ltd. (NASDAQ:KYIV, KYIVW)), today announced that Kyivstar has signed a Memorandum of Understanding (MoU) with the Ministry of Economy of Ukraine to advance the development of Ukraine’s digital infrastructure and economy. The collaboration includes exploring the establishment of a sovereign, AI-ready data center in Ukraine, with VEON expected to support implementation through its financial backing and global experti

The brands expand their partnership with a one-of-a-kind experience honoring a remarkable graduate and thousands of surprise deliveries for students nationwidePHILADELPHIA, June 26, 2026 /PRNewswire/ -- This week, Urban Outfitters and DoorDash celebrated the Class of 2030 by hosting The Ultimate Graduation Celebration, a personalized experience honoring graduating high school senior Priya Johnson in her hometown of Chicago. The event builds on the brand's recently launched partnership and is an extension of Special Delivery—Urban Outfitters' annual graduation initiative that surprises thousands of students who have sent organic graduation announcements and letters to the brand.

NEWPORT NEWS, Va., June 26, 2026 (GLOBE NEWSWIRE) -- HII (NYSE:HII) and the U.S. Navy celebrated the opening of a new facility at Newport News Shipbuilding Thursday that will enhance the work environment for sailors and shipbuilders during refueling and complex overhaul (RCOH) of nuclear-powered aircraft carriers. The Carrier Refueling Overhaul Workcenter (CROW) provides approximately 80,000 square feet of dedicated space near aircraft carriers undergoing RCOH. The facility includes office spaces for sailors and shipbuilders, as well as quality of service areas sailors can utilize while executing RCOH. "This new facility, designed to serve sailors — and benefit shipbuilders as well — is

This strategic initiative with the Ministry of Economy of Ukraine aims to fast-track digital infrastructure development, unlock scalable AI adoption, and underpin sustainable long-term economic growth. KYIV, Ukraine, GDANSK, Poland and NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Kyivstar Group Ltd. ("Kyivstar") (NASDAQ:KYIV, KYIVW)), the parent company of JSC Kyivstar, Ukraine’s leading digital operator and part of VEON Group (NASDAQ:VEON), announced the signing of a Memorandum of Understanding (MOU) between Kyivstar, VEON, and the Ministry of Economy of Ukraine to advance the development of Ukraine’s digital infrastructure and economy. The collaboration includes exploring the establishme

LAFAYETTE, La., June 26, 2026 /PRNewswire/ -- Home Bancorp, Inc. (Nasdaq: "HBCP") (the "Company"), the parent company for Home Bank, N.A. (the "Bank") (www.home24bank.com), announced that its Board of Directors has approved the separation of the roles of Chief Executive Officer and President as part of the Company's ongoing focus on management succession, leadership alignment, operational execution and long-term growth. Effective July 1, 2026, John W. Bordelon will continue to serve as Chief Executive Officer for the Company and Bank and Darren E. Guidry, currently serving as Chief Risk Officer, has been promoted to President of the Company and Bank. In connection with his promotion, Mr. Gui

New analyses from the Phase 3 Vivacity-MG3 study support the impact of IMAAVY in anti-AChR+a, anti-MuSK+b adult patients with generalized myasthenia gravis (gMG) including those early in their disease, participants with lower symptom burden and those who experienced common infectionsTo address an important evidence gap, the PETUNIAc study design will be presented – demonstrating the innovative way pregnancy outcomes data will be collected following treatment with IMAAVY IMAAVY, an immunoselective neonatal Fc receptor (FcRn) blocker, is designed to target and reduce pathogenic immunoglobulin G (IgG) autoantibodies associated with generalized myasthenia gravis (gMG)GENEVA, June 26, 2026 /PRNew

CHICAGO, June 26, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced a distribution agreement with International Medical Company ("IMC") to expand its presence in the State of Qatar for its proprietary Sky Premium Life® line of nutraceuticals and food supplements. In connection with the agreement, IMC has placed an initial purchase order of 31,000 units. Founded in 1998, IMC is Qatar's fastest-growing pharmaceutical retailer and distributor and one of the sector's leading employers, with a team of over 1,400 operating across its Sales & Marketing, Pharmacy, and Consume

SOUTHFIELD, Mich., June 26, 2026 /PRNewswire/ -- Lear Corporation (NYSE:LEA) will hold a conference call to review the company's second quarter 2026 financial results and related matters on July 31, 2026, at 9:00 a.m. EDT. To participate in the conference call: Webcast link: click hereToll-free calls: 877-883-0383International calls: 412-902-6506The conference code is 1239896.You also may listen to the live audio webcast of the call, in listen-only mode, on Lear's Investor Relations website at ir.lear.com. The webcast replay will be available two hours following the call.Note: T

Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE:RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy’s") announced that its Annual Report in Form 20-F, containing its annual consolidated financial statements prepared under International Financial Reporting Standards (IFRS), as issued by International Accounting Standards Board (IASB), for the fiscal year ended March 31, 2026 was filed with the United States Securities and Exchange Commission on May 29, 2026. The Annual Report on Form 20-F is also available on Dr. Reddy’s website, www.drreddys.com and can be accessed at https://www.drreddys.com/cms/sites/default/files/2026-05/Form_20F_Marc

Maintaining nuclear fleet will save New Yorkers $50 billion and sustain reliable emissions-free power amid rising demand Constellation (NASDAQ:CEG) has filed license renewal applications with the Nuclear Regulatory Commission (NRC) to extend the operations of Ginna Clean Energy Center and Nine Mile Point Unit 1 reactors in upstate New York to 2049. Constellation’s decision to invest in these plants to extend their safe and reliable operations into mid-century demonstrates that New York State’s renewal of its Zero Emissions Credit (ZEC) program is working as intended. "We commend Governor Hochul and the Public Service Commission for recognizing the unmatched safe, reliable, zero-emission

Culp, Inc. (NASDAQ:CULP) today announced that it will provide an online, real-time webcast and rebroadcast of its fourth quarter and fiscal 2026 conference call on Thursday, July 2, 2026, at 9:00 a.m. ET. During this call, Culp will review the company’s financial and operating results for the fourth quarter and fiscal year ended May 3, 2026. A press release announcing these results will be issued after the close of market trading on Wednesday, July 1, 2026. The live webcast of Culp’s conference call will be available under the "Upcoming Events" section on the Investor Relations page of the company’s website, www.culp.com, on Thursday, July 2, 2026, beginning at 9:00 a.m. ET. An online rep

Additional cardiac biomarker analyses further demonstrate ifetroban's cardioprotective effect in DMD patientsNASHVILLE, Tenn., June 26, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), an innovation-focused biopharmaceutical company committed to developing new products for rare diseases, today shared updated results from its Phase 2 FIGHT DMD trial evaluating ifetroban, a novel oral therapy for Duchenne muscular dystrophy (DMD) heart disease, at the annual Parent Project Muscular Dystrophy (PPMD) conference in Orlando, Florida. The presentation highlighted key updates to the primary findings in the FIGHT DMD trial, reinforcing ifetroban's potential to address the leading c

RALEIGH, N.C., June 26, 2026 /PRNewswire/ -- Cardinal Infrastructure Group, Inc. (the "Company" or "Cardinal") (NASDAQ:CDNL) today announced that it has closed its upsized underwritten public offering of 4,000,000 shares of its Class A common stock at a price to the public of $73.00 per share. In addition, the underwriters have exercised in full their option to purchase 600,000 additional shares of Class A common stock on the same terms and conditions. All shares were offered by the Company. Total gross proceeds of the offering were approximately $336 million, before underwriting discounts, commissions and other offering expenses.

Edwards Lifesciences (NYSE:EW) today announced new data presented at New York Valves 2026, the annual conference organized by the Cardiovascular Research Foundation, which reinforce the company's leadership in advancing high-quality scientific evidence and innovating for patients. These new data – spanning aortic, mitral and tricuspid therapies – provide further understanding of the complexity of structural heart disease and the need for innovative treatment options. Ahead of the planned full clinical presentation at TCT later this year, the baseline characteristics of the PROGRESS trial presented today provide new insights into the heterogeneous nature of moderate aortic stenosis (AS) pa

BOSTON, June 26, 2026 (GLOBE NEWSWIRE) -- As the U.S. Men’s National Team continues its quest to win this summer’s international tournament, belief in the squad has never been stronger. Today, Truly Hard Seltzer, the Official Hard Seltzer of U.S. Soccer, is leading that belief by putting $5 million on the line for one fan who believes as much as Truly does. This bet is Truly’s way of turning its belief in the team into something the whole world can see: if the U.S. wins it all, one believer will have the chance to win $5 million. By offering one of the largest prizes ever for its fans, Truly is proving just how much it believes in U.S. Soccer. How to enter:Starting June 26, fans

–Advisory Committee meeting scheduled for July 29, 2026––Company's Biologics License Application on track with PDUFA target action date of August 22, 2026– SAN DIEGO, June 26, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced that the Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) of the U.S. Food and Drug Administration (FDA) is planning to convene an advisory committee meeting to discuss the Company's Biologics License Application (BLA) seeking approval of Deramiocel, an investigational cell therapy for the treatment of Duchenne muscular

Advantage Solutions Ranks No. 18 Globally   Largest Agency Based in St. Louis ST. LOUIS, June 26, 2026 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ:ADV), the leading omnichannel retail solutions agency in North America, has been named the 18th largest agency company worldwide in the Ad Age Agency Report 2026, which ranks the top 25 global agency companies by revenue. The ranking also makes Advantage Solutions the largest agency headquartered in St. Louis, driven by $1.22 billion in revenue from its marketing and experiential solutions business, including AMP (Advantage Marketing Partners), its full-service marketing agency. "Advantage Solutions operates across the entire path to

Insurers seek partners to carry out AI adoption and operating model redesign, achieving measurable business outcomes, ISG Provider Lens® report says Insurance enterprises increasingly seek advisory relationships that combine strategic planning with the execution of long-term transformation, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm. The 2026 ISG Provider Lens® global Insurance — Strategic Advisory and Enablement report finds that insurers are reassessing consulting engagements as industry pressures intensify. Margin pressures, regulatory complexity, changing customer ex

Eleven sites open for patient enrollment in TakeAim CLL combination study with zanubrutinib; Company reaffirms guidance for dosing of initial five patients by end of July 2026 with data expected December 2026; Stockholders approve reverse stock split LEXINGTON, Mass., June 26, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today announced that eleven clinical sites have been initiated and are now open for patient enrollment in its Phase 2 TakeAim CLL study evaluating emavusertib in combination with zanubrutinib in patients with Chronic Lymphocytic Leukem